Could 30 years of political controversy on needle exchange programmes in Sweden contribute to scaling-up harm reduction services in the world?

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Berglund T) > (2020-2024) > Could 30 years of p...

Karlsson, NKarolinska Institutet (författare)

Could 30 years of political controversy on needle exchange programmes in Sweden contribute to scaling-up harm reduction services in the world?

Artikel/kapitelEngelska2021

Förlag, utgivningsår, omfång ...

2020-12-17
SAGE Publications,2021

Nummerbeteckningar

LIBRIS-ID:oai:prod.swepub.kib.ki.se:145984794
http://kipublications.ki.se/Default.aspx?queryparsed=id:145984794URI
https://doi.org/10.1177/1455072520965013DOI

Kompletterande språkuppgifter

Språk:engelska
Sammanfattning på:engelska

Ingår i deldatabas

SwePubSwePub

Klassifikation

Ämneskategori:ref swepub-contenttype
Ämneskategori:art swepub-publicationtype

Anmärkningar

To end the hepatitis and AIDS epidemics in the world by 2030, countries are encouraged to scale-up harm reduction services and target people who inject drugs (PWID). Blood-borne viruses (BBV) among PWID spread via unsterile injection equipment sharing and to combat this, many countries have introduced needle and syringe exchange programmes (NEP), though not without controversy. Sweden’s long, complicated harm reduction policy transition has been deviant compared to the Nordic countries. After launch in 1986, no NEP were started in Sweden for 23 years, the reasons for which are analysed in this study. Methods: Policy documents, grey literature and research mainly published in 2000–2017 were collected and analysed using a hierarchical framework, to understand how continuous build-up of evidence, decisions and key events, over time influenced NEP development. Results: Sweden’s first NEP opened in a repressive-control drug policy era with a drug-free society goal. Despite high prevalence of BBV among PWID with recurring outbreaks, growing research and key-actor support including a NEP law, no NEP were launched. Political disagreements, fluctuating actor-coalitions, questioning of research, and a municipality veto against NEP, played critical roles. With an individual-centred perspective being brought into the drug policy domain, the manifestation of a dual drug and health policy track, a revised NEP law in 2017 and removal of the veto, Sweden would see fast expansion of new NEP. Conclusions: Lessons from the Swedish case could provide valuable insight for countries about to scale-up harm reduction services including how to circumvent costly time- and resource-intensive obstacles and processes involving ideological and individual moral dimensions.

Biuppslag (personer, institutioner, konferenser, titlar ...)

Berglund, TKarolinska Institutet (författare)
Ekstrom, AMKarolinska Institutet (författare)
Hammarberg, AKarolinska Institutet (författare)
Tammi, T (författare)
Karolinska Institutet (creator_code:org_t)

Sammanhörande titlar

Ingår i:Nordisk alkohol- & narkotikatidskrift : NAT: SAGE Publications38:1, s. 66-881458-6126
Ingår i:Nordic Studies on Alcohol and Drugs: SAGE Publications38:1, s. 66-881455-0725

Internetlänk

Hitta via bibliotek

Nordisk alkohol- & narkotikatidskrift : NAT (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...: Karlsson, N; Berglund, T; Ekstrom, AM; Hammarberg, A; Tammi, T

Artiklar i publikationen: Nordisk alkohol- ...; Nordic Studies o ...

Av lärosätet: Karolinska Institutet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se